HMCIB No.7 Special Purpose Acquisition Co

Capital Structure and Liquidity HMCIB No.7 maintains a strong liquidity position with KRW 1.57 trillion in cash and equivalents, representing 97% of total assets. The company's debt-to-equity ratio of 0.08 indicates a conservative capital structure, with long-term debt at KRW 1.22 trillion and total equity at KRW 1.49 trillion. The price-to-book ratio of 1.03 and price-to-tangible-book ratio of 1.03 suggest market valuation is closely aligned with tangible asset value. ### Profitability and Returns Despite zero revenue, HMCIB No.7 reported a net income of KRW 270.8 billion and operating income of -KRW 31.4 million in the latest period. Return on equity (ROE) of 1.82% and return on assets (ROA) of 1.68% reflect minimal asset utilization and low operational returns, consistent with SPACs in pre-merger phases. ### Segments and Geographic Exposure The company operates as a single-purpose SPAC with no disclosed revenue segments. Its geographic exposure is entirely concentrated in South Korea, with no international operations or revenue diversification reported. ### Growth Trajectory HMCIB No.7 has no revenue history and operates in a pre-revenue phase. The company's future growth depends on the success of its merger with a target in high-growth sectors such as renewable energy or biopharmaceuticals. No numerical growth projections are available for the current or next fiscal year. ### Risk Factors Liquidity risk is low, with no immediate filing-based flags detected. Dilution risk is also low, with no near-term pressure from share issuance or convertible instruments. The valuation is adjusted for SPAC-specific accounting, with no material deviations in custom_valuations adjustments_applied. ### Recent Events No recent filings, transcripts, or material events were disclosed in the input data. The company remains in the pre-merger phase, with no public updates on target acquisition progress.